N T Mueller1, R Whyatt2, L Hoepner2, S Oberfield3, M G Dominguez-Bello4, E M Widen1, A Hassoun3, F Perera2, A Rundle5. 1. 1] Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA [2] Institute of Human Nutrition and Department of Medicine, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA. 2. Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA. 3. Department of Pediatrics, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA. 4. Division of Translational Medicine, New York University School of Medicine, New York, NY, USA. 5. Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA.
Abstract
BACKGROUND/ OBJECTIVES: Cesarean section (CS) and antibiotic use during pregnancy may alter normal maternal-offspring microbiota exchange, thereby contributing to aberrant microbial colonization of the infant gut and increased susceptibility to obesity later in life. We hypothesized that (i) maternal use of antibiotics in the second or third trimester of pregnancy and (ii) CS are independently associated with higher risk of childhood obesity in the offspring. SUBJECTS/ METHODS: Of the 727 mothers enrolled in the Northern Manhattan Mothers and Children Study, we analyzed the 436 mother-child dyads followed until 7 years of age with complete data. We ascertained prenatal antibiotic use by a questionnaire administered late in the third trimester, and delivery mode by medical record. We derived age- and sex-specific body mass index (BMI) z-scores using the CDC SAS Macro, and defined obesity as BMI z⩾95th percentile. We used binary regression with robust variance and linear regression models adjusted for maternal age, ethnicity, pre-gravid BMI, maternal receipt of public assistance, birth weight, sex, breastfeeding in the first year and gestational antibiotics or delivery mode. RESULTS: Compared with children not exposed to antibiotics during the second or third trimester, those exposed had 84% (33-154%) higher risk of obesity, after multivariable adjustment. Second or third trimester antibiotic exposure was also positively associated with BMI z-scores, waist circumference and % body fat (all P<0.05). Independent of prenatal antibiotic usage, CS was associated with 46% (8-98%) higher offspring risk of childhood obesity. Associations were similar for elective and non-elective CS. CONCLUSIONS: In our cohort, CS and exposure to antibiotics in the second or third trimester were associated with higher offspring risk of childhood obesity. Future studies that address the limitations of our study are warranted to determine if prenatal antibiotic use is associated with offspring obesity. Research is also needed to determine if alterations in neonatal gut microbiota underlie the observed associations.
BACKGROUND/ OBJECTIVES: Cesarean section (CS) and antibiotic use during pregnancy may alter normal maternal-offspring microbiota exchange, thereby contributing to aberrant microbial colonization of the infant gut and increased susceptibility to obesity later in life. We hypothesized that (i) maternal use of antibiotics in the second or third trimester of pregnancy and (ii) CS are independently associated with higher risk of childhood obesity in the offspring. SUBJECTS/ METHODS: Of the 727 mothers enrolled in the Northern Manhattan Mothers and Children Study, we analyzed the 436 mother-child dyads followed until 7 years of age with complete data. We ascertained prenatal antibiotic use by a questionnaire administered late in the third trimester, and delivery mode by medical record. We derived age- and sex-specific body mass index (BMI) z-scores using the CDC SAS Macro, and defined obesity as BMI z⩾95th percentile. We used binary regression with robust variance and linear regression models adjusted for maternal age, ethnicity, pre-gravid BMI, maternal receipt of public assistance, birth weight, sex, breastfeeding in the first year and gestational antibiotics or delivery mode. RESULTS: Compared with children not exposed to antibiotics during the second or third trimester, those exposed had 84% (33-154%) higher risk of obesity, after multivariable adjustment. Second or third trimester antibiotic exposure was also positively associated with BMI z-scores, waist circumference and % body fat (all P<0.05). Independent of prenatal antibiotic usage, CS was associated with 46% (8-98%) higher offspring risk of childhood obesity. Associations were similar for elective and non-elective CS. CONCLUSIONS: In our cohort, CS and exposure to antibiotics in the second or third trimester were associated with higher offspring risk of childhood obesity. Future studies that address the limitations of our study are warranted to determine if prenatal antibiotic use is associated with offspring obesity. Research is also needed to determine if alterations in neonatal gut microbiota underlie the observed associations.
Authors: Jennifer H Steel; Sotiris Malatos; Nigel Kennea; A David Edwards; Lynda Miles; Philip Duggan; Peter R Reynolds; Robert G Feldman; Mark H F Sullivan Journal: Pediatr Res Date: 2005-01-19 Impact factor: 3.756
Authors: Robin M Whyatt; Dana B Barr; David E Camann; Patrick L Kinney; John R Barr; Howard F Andrews; Lori A Hoepner; Robin Garfinkel; Yair Hazi; Andria Reyes; Judyth Ramirez; Yesenia Cosme; Frederica P Perera Journal: Environ Health Perspect Date: 2003-05 Impact factor: 9.031
Authors: A Mor; S Antonsen; J Kahlert; V Holsteen; S Jørgensen; J Holm-Pedersen; H T Sørensen; O Pedersen; V Ehrenstein Journal: Int J Obes (Lond) Date: 2015-07-16 Impact factor: 5.095
Authors: Srinivas Acharya Nanduri; Susan Petit; Chad Smelser; Mirasol Apostol; Nisha B Alden; Lee H Harrison; Ruth Lynfield; Paula S Vagnone; Kari Burzlaff; Nancy L Spina; Elizabeth M Dufort; William Schaffner; Ann R Thomas; Monica M Farley; Jennifer H Jain; Tracy Pondo; Lesley McGee; Bernard W Beall; Stephanie J Schrag Journal: JAMA Pediatr Date: 2019-03-01 Impact factor: 16.193
Authors: Morgan R Chojnacki; Hannah D Holscher; Alaina R Balbinot; Lauren B Raine; John R Biggan; Anne M Walk; Arthur F Kramer; Neal J Cohen; Charles H Hillman; Naiman A Khan Journal: Early Hum Dev Date: 2019-01-12 Impact factor: 2.079
Authors: Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Juan P Kusanovic; Nikolina Docheva; Alicia Martinez-Varea; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo Journal: J Perinat Med Date: 2016-01 Impact factor: 1.901
Authors: Elizabeth M Widen; Robin M Whyatt; Lori A Hoepner; Judyth Ramirez-Carvey; Sharon E Oberfield; Abeer Hassoun; Frederica P Perera; Dympna Gallagher; Andrew G Rundle Journal: Am J Clin Nutr Date: 2015-10-21 Impact factor: 7.045